MACRO
BRENTWTINAT GASGOLDSILVERPLATINUMPALLADIUMGOLD/SILVERCOPPERGASOLINECOCOAOJCANOLAS&P 500NASDAQDXYFED RATEBTCTASIDFMADXBRENTWTINAT GASGOLDSILVERPLATINUMPALLADIUMGOLD/SILVERCOPPERGASOLINECOCOAOJCANOLAS&P 500NASDAQDXYFED RATEBTCTASIDFMADX
40

Mouwasat Medical Services Co.

4002XSAU
Saudi Exchange·Healthcare
SAR 65.20
▼︎ 0.84%(-0.55)
Live
Data as of 13 May 2026
Open
SAR 65.70
High
SAR 65.70
Low
SAR 65.20
Volume
439.6K
52W High
SAR 80.70
52W Low
SAR 58.65
1W
-3.76%
1M
-7.58%
3M
+1.09%
6M
-2.69%
YTD
-2.69%
1Y
-8.81%

Mīzān Analysis

44/60

Positive momentum and strong health

Value6.4Growth9.2Health9.0Income4.0Momentum8.4Sentiment7.0
4002Sector
Market Cap
13.6B SAR
P/E
16.5
Revenue Growth
17.1%
Div Yield
1.47%

Rewards

No standout positive signals at current scores.

Risk Analysis

No significant risk flags at current scores.

Scores computed 13 May 2026

Fundamentals

Market Cap
13.6B SAR
P/E Ratio
16.55
P/B Ratio
3.60
EPS
SAR 4.11
EPS Growth
38.7%
Revenue
3.2B SAR
Revenue Growth
17.1%
Net Income
822.0M SAR
Profit Margin
25.5%
Debt / Assets
Dividend Yield
1.47%
Dividend Per Share
SAR 1.00
Shares Outstanding
200.0M
Reporting Period: 2025-12-31Data as of May 1, 2026

Mizān Summary

News

Sector News10Industry & macro context
Trade ministers discuss final steps for GCC-UK FTA
Qatar Tribune· 1 day agoNeutralEconomy
UAE launches global plan to reach 42 million people, eradicate river blindness by 2030
Economy Middle East· 3 days agoNeutral
UAE Business: PureHealth surpasses $1.72bn in local procurement spend
Gulf Daily News· 7 days agoEconomy
Bahrain SWF Mumtalakat, SandboxAQ to boost Bahrain’s biotech sector
MSN· 12 days agoNeutralEconomy
Abu Dhabi’s PureHealth Q1 2026 revenue rises 10 percent to $2 billion on global expansion
Economy Middle East· 13 days agoNeutral
Omani delegation visits China to explore high tech pharmaceutical and medical ventures
Times of Oman· 16 days agoNeutralEconomy
Memo to enhance training, employment in pharmaceutical industry inked
وكالة الانباء الاردنية· 23 days agoNeutralEconomy
Trump nominates Erica Schwartz as CDC director amid turmoil around leadership, vaccine policy
CNBC Business· 27 days agoNeutralMarket Movers
RFK Jr.'s peptide policy could boost Hims & Hers as its GLP-1 business evolves
CNBC Business· 28 days agoPositiveMarket Movers
Hims & Hers stock jumps as U.S. moves forward with plan to reassess popular peptides
MarketWatch Top Stories· 28 days agoPositiveEconomy

Events

No upcoming corporate events